Northern Biologics Inc. Company
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis.
Founded Date:
2014
Last Funding Type:
Post-IPO Equity
Headquarters:
Canada
Investors Number:
3
Technology:
Anti-infective Drugs
Employee Number:
11-50
Industry:
PharmTech
Estimated Revenue:
$1M to $10M
Funding Status:
M&A
Investor Type:
For Profit
Total Funding:
$20.7M